Catalyst Wire Dossier Catalyst Wire Dossier

Oli

· Baymatob Operations Pty Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oli, covering 2025-08-08 to 2025-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage [NA]

See pricing